Myriad Genetics (MYGN) Reports In-Line Q3 EPS
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $5.99 -0.17%
EPS Growth %: -220.0%
Financial Fact:
Total revenue: 177.5M
Today's EPS Names:
CRMT, More
EPS Growth %: -220.0%
Financial Fact:
Total revenue: 177.5M
Today's EPS Names:
CRMT, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $167.3 million versus the consensus estimate of $165.04 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank
- FactSet Research Systems (FDS) PT Raised to $253 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
